---
figid: PMC10999658__gr7
figtitle: Molecular mechanism underlying CE accumulation in ccRCC and suppression
  of cancer progression upon CE depletion
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10999658
filename: PMC10999658__gr7.jpg
figlink: /pmc/articles/PMC10999658/figure/F7
number: F7
caption: Molecular mechanism underlying CE accumulation in ccRCC and suppression of
  cancer progression upon CE depletion. The schematic shows that VHL mutation activates
  PI3K/AKT/mTOR/SREBPs pathway in a HIFα-dependent manner. The excess free cholesterol
  (FC) is then esterified into CEs by SOAT-1 and stored into LDs. The red arrows indicate
  the consequences of CE depletion by avasimibe treatment. Inhibition of cholesterol
  esterification disturbs the cholesterol homeostasis by downregulations of SREBPs
  and lipoprotein uptake. Consequently, the reduced cholesterol level on cell membrane
  leads to downregulations of integrin and MAPK signaling pathways that further impair
  ccRCC progression
papertitle: VHL mutation drives human clear cell renal cell carcinoma progression
  through PI3K/AKT-dependent cholesteryl ester accumulation
reftext: Shuo Zhang, et al. eBioMedicine. 2024 May;103(NA).
year: '2024'
doi: 10.1016/j.ebiom.2024.105070
journal_title: eBioMedicine
journal_nlm_ta: eBioMedicine
publisher_name: Elsevier
keywords: Stimulated Raman scattering microscopy | Raman spectromicroscopy | Clear
  cell renal cell carcinoma | Cholesterol metabolism | VHL mutation
automl_pathway: 0.9329576
figid_alias: PMC10999658__F7
figtype: Figure
redirect_from: /figures/PMC10999658__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10999658__gr7.html
  '@type': Dataset
  description: Molecular mechanism underlying CE accumulation in ccRCC and suppression
    of cancer progression upon CE depletion. The schematic shows that VHL mutation
    activates PI3K/AKT/mTOR/SREBPs pathway in a HIFα-dependent manner. The excess
    free cholesterol (FC) is then esterified into CEs by SOAT-1 and stored into LDs.
    The red arrows indicate the consequences of CE depletion by avasimibe treatment.
    Inhibition of cholesterol esterification disturbs the cholesterol homeostasis
    by downregulations of SREBPs and lipoprotein uptake. Consequently, the reduced
    cholesterol level on cell membrane leads to downregulations of integrin and MAPK
    signaling pathways that further impair ccRCC progression
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HSD11B1
  - ALB
  - APOA1
  - APOA2
  - APOE
  - CLU
  - VHL
  - HIF1A
  - EPAS1
  - HIF3A
  - MTOR
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - SOAT1
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CAV1
  - Cholesterol
  - Cancer
---
